Insulin Price Reduction Act
Latest action · Oct 30, 2019 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedOct 29, 2019
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Insulin Price Reduction Act
This bill prohibits health insurance plan issuers and pharmacy benefits managers (PBMs) from receiving rebates or discounts for insulin from manufacturers who certify that its current insulin list price has been reduced to an amount no greater than what the list price was for the same insulin on July 1, 2006. This restriction does not apply to discounts provided to insurance plan holders at retail sale or to flat-rate fees for service paid to PBMs. Further, insurance plans are prohibited from applying a deductible to insulin that has received such price certification.
A manufacturer may certify insulin prices by submitting to the Department of Health and Human Services data about the list price of any insulin the manufacturer has produced since January 1, 2000, and by setting the current list price for an insulin product at the 2006 rate. To remain certified, a manufacturer may not increase the list price of insulin by more than the annual increase in the medical care consumer price index. A manufacturer may certify the price of an insulin product for which it did not have a list price in 2006 by reducing the list price of such insulin to the weighted average list price in 2006 of specified insulin categories.
This bill also applies to Medicare prescription drug benefits. The bill sets the rebate for insulin under Medicaid based on the average manufacturer price of insulin during the last fiscal quarter of 2019, increasing by the medical care consumer price index thereafter.
Cosponsors 54
Members who signed on, in the order they did. Signatures ran from Oct 29, 2019 to Sep 11, 2020; 1 is an original cosponsor, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-NY | Tom Reed | Original | Oct 29, 2019 |
| D-TX | Colin Z. Allred | Nov 1, 2019 | |
| R-PA | Brian K. Fitzpatrick | Nov 12, 2019 | |
| D-MI | Elissa Slotkin | Nov 12, 2019 | |
| D-TX | Sylvia R. Garcia | Nov 12, 2019 | |
| D-FL | Alcee L. Hastings | Nov 22, 2019 | |
| D-KS | Sharice Davids | Dec 19, 2019 | |
| D-UT | Ben McAdams | Feb 14, 2020 | |
| D-DC | Eleanor Holmes Norton | Feb 14, 2020 | |
| D-MI | Haley M. Stevens | Feb 14, 2020 | |
| D-CA | Josh Harder | Feb 14, 2020 | |
| D-PA | Susan Wild | Feb 14, 2020 | |
| D-NH | Ann M. Kuster | Feb 28, 2020 | |
| D-NC | David E. Price | Feb 28, 2020 | |
| D-MI | Debbie Dingell | Feb 28, 2020 | |
| D-FL | Debbie Wasserman Schultz | Feb 28, 2020 | |
| D-NY | Max Rose | Feb 28, 2020 | |
| D-CA | Maxine Waters | Feb 28, 2020 | |
| D-GA | Sanford D. Bishop, Jr. | Feb 28, 2020 | |
| D-NY | Sean Patrick Maloney | Feb 28, 2020 | |
| D-MN | Betty McCollum | Mar 5, 2020 | |
| D-PA | Brendan F. Boyle | Mar 5, 2020 | |
| D-NY | Brian Higgins | Mar 5, 2020 | |
| D-ME | Chellie Pingree | Mar 5, 2020 | |
| D-IA | Cynthia Axne | Mar 5, 2020 | |
| D-IL | Danny K. Davis | Mar 5, 2020 | |
| D-FL | Darren Soto | Mar 5, 2020 | |
| D-RI | David N. Cicilline | Mar 5, 2020 | |
| D-CO | Ed Perlmutter | Mar 5, 2020 | |
| D-VA | Gerald E. Connolly | Mar 5, 2020 | |
| D-WA | Kim Schrier | Mar 5, 2020 | |
| D-OH | Marcy Kaptur | Mar 5, 2020 | |
| D-NY | Nita M. Lowey | Mar 5, 2020 | |
| D-NV | Susie Lee | Mar 5, 2020 | |
| D-FL | Theodore E. Deutch | Mar 5, 2020 | |
| D-MO | Wm. Lacy Clay | Mar 5, 2020 | |
| D-MD | C. A. Dutch Ruppersberger | May 27, 2020 | |
| D-CA | Pete Aguilar | May 27, 2020 | |
| D-MN | Angie Craig | Jun 22, 2020 | |
| D-NJ | Donald M. Payne, Jr. | Jun 22, 2020 | |
| D-CT | Jahana Hayes | Jun 22, 2020 | |
| D-TX | Joaquin Castro | Jun 22, 2020 | |
| D-CT | John B. Larson | Jun 22, 2020 | |
| D-GU | Michael F. Q. San Nicolas | Jun 22, 2020 | |
| R-PA | Mike Kelly | Jun 22, 2020 | |
| D-TX | Sheila Jackson Lee | Jun 22, 2020 | |
| D-MS | Bennie G. Thompson | Jul 9, 2020 | |
| D-OR | Earl Blumenauer | Jul 9, 2020 | |
| D-VA | Elaine G. Luria | Jul 9, 2020 | |
| D-IL | Jesús G. "Chuy" García | Jul 9, 2020 | |
| D-TN | Steve Cohen | Jul 9, 2020 | |
| D-NY | Jose E. Serrano | Jul 31, 2020 | |
| D-NY | Nydia M. Velázquez | Sep 11, 2020 | |
| D-TX | Vicente Gonzalez | Sep 11, 2020 |
Committees 2
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Oct 29, 2019 |
| Health Subcommittee | Referred Oct 30, 2019 | |
| House | Ways and Means Committee | Referred Oct 29, 2019 |
Actions 3
Everything that happened, newest first.
- Oct 30, 2019Referred to the Subcommittee on Health.
- Oct 29, 2019Introduced in House
- Oct 29, 2019Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 165, no. 171, October 29, 2019, page H8595.
Printed hearings 1
Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.
| Number | Hearing | Committee | Held |
|---|---|---|---|
| Serial No. 116-11 | HEARING WITH SECRETARY OF COMMERCE WILBUR L. ROSS, JR.95 pages | Oversight and Government Reform Committee | Mar 14, 2019 |
CRS reports 1
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
Cite it 1
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| R46741 | Drug Pricing and Intellectual Property: The Legislative Landscape for the 117th Congress | Report | Mar 31, 2021 |
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 2199 | Insulin Price Reduction Act | Related bill | Jul 22, 2019 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To provide patient protections with respect to the cost of insulin.
- Short Title(s) as Introduced
- Insulin Price Reduction Act
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Oct 29, 2019Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
